CDC20 Regulates the Progression of Clear Cell Renal Cell Carcinoma via the Wnt/β‐Catenin Signaling Pathway
Genetics Research · 2026-01 · 2026 (1)
DOI: 10.1155/genr/1270981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics Research, online erschienen am 19.07.2026. Verfasst von YuHu Hao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China, sdu.edu.cn. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Cdc20 Proteins, Kidney Neoplasms, Wnt Signaling Pathway. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Traditional Chinese Medicine Science & Technology Project of Shandong Province, Medical and Health Science and Technology Development Project of Shandong Province.
Abstract (Originalsprache)
Objective
To detect the expression level of cell division cycle 20 homolog (CDC20) in clear cell renal cell carcinoma (ccRCC) and to study the biological function of CDC20 in ccRCC.
Methods
CDC20 expression levels and clinical significance of ccRCC were determined using the Cancer Genome Atlas (TCGA) database. We detected the expression level of CDC20 in ccRCC with the help of immunohistochemistry (IHC). The effect of CDC20 on the proliferation of renal cancer cells was investigated using EDU and CCK‐8 proliferation assays. We used wound healing assays and Transwell assays to determine the effects of CDC20 on renal cancer cell migration and invasion and Wnt signaling pathway agonists in recovery experiments. The mechanism of CDC20 in ccRCC was detected using western blotting. Finally, the effect of CDC20 on renal cancer cells was verified in vivo in a nude mouse xenograft model.
Results
Bioinformatics analysis found that CDC20 was upregulated in ccRCC, and its high expression was associated with poor prognosis in kidney renal cell carcinoma (KIRC) patients. In addition, we detected high expression of CDC20 in KIRC tissues, consistent with the results of bioinformatics analysis. Besides, knockdown of CDC20 can inhibit the biological functions of renal cancer cells. The recovery experiment proved that the biological function of the originally inhibited renal cancer cells was restored. In vivo, low expression of CDC20 can inhibit tumor growth.
Conclusions
As CDC20 is highly expressed in KIRC tissues, it can be used as both a therapeutic target and a prognostic marker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China, sdu.edu.cn.
- Department of Urology, Dongying People's Hospital, Dongying 257000, China, dysrmyy.com/.
- Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China, sph.com.cn.
ORCID-Profile: YuHu Hao, Qinghua Xia
Förderung
- National Natural Science Foundation of China
- Traditional Chinese Medicine Science & Technology Project of Shandong Province
- Medical and Health Science and Technology Development Project of Shandong Province
Zitieren
APA
Hao, Y., Zhao, L., Sun, Y., Peng, F., Xu, T., Deng, W., & Xia, Q. (2026). CDC20 Regulates the Progression of Clear Cell Renal Cell Carcinoma via the Wnt/β‐Catenin Signaling Pathway. Genetics Research, 2026(1). https://doi.org/10.1155/genr/1270981
Vancouver
Hao Y, Zhao L, Sun Y, Peng F, Xu T, Deng W, et al. CDC20 Regulates the Progression of Clear Cell Renal Cell Carcinoma via the Wnt/β‐Catenin Signaling Pathway. Genetics Research. 2026;2026(1). doi:10.1155/genr/1270981
BibTeX
@article{Hao2026,
author = {Hao, YuHu and Zhao, Leizuo and Sun, Yanning and Peng, Fan and Xu, Tingting and Deng, Wentao and Xia, Qinghua},
title = {CDC20 Regulates the Progression of Clear Cell Renal Cell Carcinoma via the Wnt/β‐Catenin Signaling Pathway},
journal = {Genetics Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/genr/1270981}
}
EUVIMED